KALA
Kala Pharmaceuticals (KALA)
$
25About Kala Pharmaceuticals (KALA)
KALA BIO, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.
Details
Daily high
$7.60
Daily low
$7.01
Price at open
$7.01
52 Week High
$8.79
52 Week Low
$4.21
Market cap
33.4M
Dividend yield
0.00%
Volume
17,502
Avg. volume
46,654
P/E ratio
-.58
Kala Pharmaceuticals News
Details
Daily high
$7.60
Daily low
$7.01
Price at open
$7.01
52 Week High
$8.79
52 Week Low
$4.21
Market cap
33.4M
Dividend yield
0.00%
Volume
17,502
Avg. volume
46,654
P/E ratio
-.58